Skip to content

Efficacy of digital based exercise intervention in adults with metabolic associated fatty liver disease

Efficacy of digital based exercise intervention in adults with metabolic associated fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083477
Enrollment
Unknown
Registered
2024-04-26
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic associated fatty liver disease

Interventions

Digital intervention group:A comprehensive intervention based on exercise intervention through a digital platform for 3 months
Active-control group:Self-supervised for 3 months

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with MAFLD in the outpatient department. 2.24kg/m^2 = 238 dB/m. 5.Weekly drinking volume (alcohol content) in the past half year was <140g for men and <70g for women. 6.Ability to act independently; able to actively cooperate with doctors' follow-up and conduct regular review according to medical advice. 7.Voluntary signed the informed consent, agreed and actively cooperated with this study.

Exclusion criteria

Exclusion criteria: 1.Patients with viral hepatitis, drug hepatitis, alcoholic fatty liver, organ failure, severe liver and renal insufficiency. 2.Patients with severe hypertension, heart disease, diabetes mellitus, mental and neurological diseases, motor dysfunction and other exercise contraindications. 3. Patients who have undergone bariatric surgery in the past 1 year or have taken weight-loss drugs in the last 3 months and lost more than 10% of their body weight. 4.Patients or family members are unable to perform digital intervention programs using smartphones.Patients or family members lack the fundamental digital literacy required to engage with digital intervention programs via smartphones, including the ability to install apps, upload data, and navigate the platform. 5.Subjects are also participating in other clinical research trials. 6.Claustrophobia, patients too large to enter the MRI scanner, and patients with MRI contraindications (such as certain metal implants).

Design outcomes

Primary

MeasureTime frame
Liver MRI proton density fat fraction (MRI- PDFF);

Secondary

MeasureTime frame
Liver function;Blood lipid;Blood glucose;LSM value measured by FibroScan;Anthropometric parameters;Body composition;Blood pressure;Compliance;

Countries

China

Contacts

Public ContactZhu Yi

Jiangsu Province Hospital

ZhuYi1981@njmu.edu.cn+86 137 0516 4030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026